The program will bring together experts from across the FDA for a team-based review, rather than having an application move across numerous offices within the agency before getting a yay or nay.
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews Read More »
The robot maker, which is expanding globally, believes it can stand out in competition with market leader Intuitive Surgical with a technologically advanced system that is affordable and accessible.
SS Innovations’ robot used in its first cardiac surgery in Americas Read More »
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Anne Wojcicki wins bid to buy back 23andMe for $305M Read More »
At the insurer’s investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — which accounts for the bulk of its revenue — while allowing that there’s room for improvement.
Humana’s cautious defense of the Medicare Advantage program Read More »
Una de las preguntas más fundamentales de la neurociencia es cómo el cerebro puede gestionar los recuerdos. Se cree que los recuerdos se almacenan mediante cambios biofísicos y moleculares en conjuntos neuronales llamados engramas, distribuidos en diferentes regiones cerebrales. …
La búsqueda de las huellas biofísicas de los recuerdos en el cerebro Read More »
Nearly $30 million in tax incentive awards are expected to add 1,519 new life sciences jobs in Massachusetts, with about 52% of the positions spread over Boston and Cambridge. Vertex, which received the largest award, will create hundreds of roles in Boston.
$30M in Tax Incentives Fuel Job Growth: 1,500+ New Roles Coming to Massachusetts Read More »
Mediante su singular método consistente en provocar eclipses solares artificiales en el espacio, las dos naves de la misión Proba-3 de la Agencia Espacial Europea ya han captado sus primeras imágenes de la atmósfera exterior del Sol: la corona solar. Los dos sat& …
The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, the entire gene editing space would see a boost at the markets.
Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical Read More »
Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including Alzheimer’s.
La inteligencia artificial ha comenzado a revolucionar la radiología, a juzgar por los espectaculares resultados que ha logrado un nuevo sistema de ese tipo, especializado en examinar radiografías, durante las primeras pruebas a las que ha sido sometido. Así lo ha compr …
Inteligencia artificial para examinar radiografías Read More »
